Zdrowie i gospodarka · 26/07/2011
FDA Publishes Guidance for Repetitive Transcranial Magnetic Stimulation Systems
The FDA has released a guidance document outlining the special controls for Class II devices, including repetitive transcranial magnetic stimulation (rTMS) systems, to ensure compliance with FDA regulations.
Source: Federal Register — Health and Human ServicesOpen original release →